These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 37127611)

  • 1. Development of a novel, entirely herbal-based mouthwash effective against common oral bacteria and SARS-CoV-2.
    Bencze B; Temesfői V; Das S; Papp H; Kaltenecker P; Kuczmog A; Jakab F; Kocsis B; Kőszegi T
    BMC Complement Med Ther; 2023 May; 23(1):138. PubMed ID: 37127611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salivary and Nasal Detection of the SARS-CoV-2 Virus After Antiviral Mouthrinses (BBCovid): A structured summary of a study protocol for a randomised controlled trial.
    Carrouel F; Viennot S; Valette M; Cohen JM; Dussart C; Bourgeois D
    Trials; 2020 Nov; 21(1):906. PubMed ID: 33138848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effective
    Davies K; Buczkowski H; Welch SR; Green N; Mawer D; Woodford N; Roberts ADG; Nixon PJ; Seymour DW; Killip MJ
    J Gen Virol; 2021 Apr; 102(4):. PubMed ID: 33913803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial mouthwashes (gargling) and nasal sprays administered to patients with suspected or confirmed COVID-19 infection to improve patient outcomes and to protect healthcare workers treating them.
    Burton MJ; Clarkson JE; Goulao B; Glenny AM; McBain AJ; Schilder AG; Webster KE; Worthington HV
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD013627. PubMed ID: 32936948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of antimicrobial mouthwashes (gargling) and nasal sprays by healthcare workers to protect them when treating patients with suspected or confirmed COVID-19 infection.
    Burton MJ; Clarkson JE; Goulao B; Glenny AM; McBain AJ; Schilder AG; Webster KE; Worthington HV
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD013626. PubMed ID: 32936949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro virucidal activity of mouthwashes on SARS-CoV-2.
    Buonavoglia A; Lanave G; Marchi S; Lorusso P; Montomoli E; Martella V; Camero M; Prati C; Trombetta CM
    Oral Dis; 2022 Nov; 28 Suppl 2():2509-2515. PubMed ID: 35398970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CPC-containing oral rinses inactivate SARS-CoV-2 variants and are active in the presence of human saliva.
    Anderson ER; Patterson EI; Richards S; Pitol AK; Edwards T; Wooding D; Buist K; Green A; Mukherjee S; Hoptroff M; Hughes GL
    J Med Microbiol; 2022 Feb; 71(2):. PubMed ID: 35180046
    [No Abstract]   [Full Text] [Related]  

  • 8. Antimicrobial mouthwashes (gargling) and nasal sprays to protect healthcare workers when undertaking aerosol-generating procedures (AGPs) on patients without suspected or confirmed COVID-19 infection.
    Burton MJ; Clarkson JE; Goulao B; Glenny AM; McBain AJ; Schilder AG; Webster KE; Worthington HV
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD013628. PubMed ID: 32936947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of Cetylpyridinium Chloride mouthwash against SARS-CoV-2: A systematic review of randomized controlled trials.
    D'Amico F; Moro M; Saracino M; Marmiere M; Cilona MB; Lloyd-Jones G; Zangrillo A
    Mol Oral Microbiol; 2023 Jun; 38(3):171-180. PubMed ID: 36808889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of oral antiseptics in reducing SARS-CoV-2 infectivity: evidence from a randomized double-blind clinical trial.
    Sánchez Barrueco Á; Mateos-Moreno MV; Martínez-Beneyto Y; García-Vázquez E; Campos González A; Zapardiel Ferrero J; Bogoya Castaño A; Alcalá Rueda I; Villacampa Aubá JM; Cenjor Español C; Moreno-Parrado L; Ausina-Márquez V; García-Esteban S; Artacho A; López-Labrador FX; Mira A; Ferrer MD
    Emerg Microbes Infect; 2022 Dec; 11(1):1833-1842. PubMed ID: 35796097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized clinical trial to assess the impact of oral intervention with cetylpyridinium chloride to reduce salivary SARS-CoV-2 viral load.
    Tarragó-Gil R; Gil-Mosteo MJ; Aza-Pascual-Salcedo M; Alvarez MJL; Ainaga RR; Gimeno NL; Viñuales RF; Fernández YM; Marco JM; Bolsa EA; Sancho JB; Cajo SA; Perez-Zsolt D; Raïch-Regué D; Muñoz-Basagoiti J; Izquierdo-Useros N; Pociello VB; León R; Peris DS
    J Clin Periodontol; 2023 Mar; 50(3):288-294. PubMed ID: 36345827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo evaluation of the virucidal efficacy of chlorhexidine and povidone-iodine mouthwashes against salivary SARS-CoV-2. A randomized-controlled clinical trial.
    Elzein R; Abdel-Sater F; Fakhreddine S; Hanna PA; Feghali R; Hamad H; Ayoub F
    J Evid Based Dent Pract; 2021 Sep; 21(3):101584. PubMed ID: 34479668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial effects of a mouthwash containing an antiviral phthalocyanine derivative on the length of hospital stay for COVID-19: randomised trial.
    da Silva Santos PS; da Fonseca Orcina B; Machado RRG; Vilhena FV; da Costa Alves LM; Zangrando MSR; de Oliveira RC; Soares MQS; Simão ANC; Pietro ECIN; Kuroda JPG; de Almeida Benjamim IA; Araujo DB; Toma SH; Flor L; Araki K; Durigon EL
    Sci Rep; 2021 Oct; 11(1):19937. PubMed ID: 34620904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of Povidone-Iodine Nasal and Oral Antiseptic Preparations Against Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV-2).
    Pelletier JS; Tessema B; Frank S; Westover JB; Brown SM; Capriotti JA
    Ear Nose Throat J; 2021 Apr; 100(2_suppl):192S-196S. PubMed ID: 32951446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Povidone-Iodine as a Pre-Procedural Mouthwash to Reduce the Salivary Viral Load of SARS-CoV-2: A Systematic Review of Randomized Controlled Trials.
    Garcia-Sanchez A; Peña-Cardelles JF; Ordonez-Fernandez E; Montero-Alonso M; Kewalramani N; Salgado-Peralvo AO; Végh D; Gargano A; Parra G; Guerra-Guajardo LI; Kozuma W
    Int J Environ Res Public Health; 2022 Mar; 19(5):. PubMed ID: 35270569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial Efficacy of Extemporaneously Prepared Herbal Mouthwashes.
    Dua K; Sheshala R; Al-Waeli HA; Gupta G; Chellappan DK
    Recent Pat Drug Deliv Formul; 2015; 9(3):257-61. PubMed ID: 26051152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is chlorhexidine mouthwash effective in lowering COVID-19 viral load? A systematic review.
    Rahman GS; Alshetan AAN; Alotaibi SSO; Alaskar BMI; Baseer MA
    Eur Rev Med Pharmacol Sci; 2023 Jan; 27(1):366-377. PubMed ID: 36647885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effectiveness of mouthwash against SARS-CoV-2 infection: A review of scientific and clinical evidence.
    Chen MH; Chang PC
    J Formos Med Assoc; 2022 May; 121(5):879-885. PubMed ID: 34666923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Could certain mouthwashes reduce transmissibility of COVID-19?
    Elmahgoub F; Coll Y
    Evid Based Dent; 2021 Jan; 22(2):82-83. PubMed ID: 34172918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the efficacy of herbal mouth rinse with commercially available mouth rinses: A clinical trial.
    Jeddy N; Ravi S; Radhika T; Sai Lakshmi LJ
    J Oral Maxillofac Pathol; 2018; 22(3):332-334. PubMed ID: 30651676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.